about
Beyond heparinization: design of highly potent thrombin inhibitors suitable for surface couplingConstruction and use of a library of bona fide heparins employing 1H NMR and multivariate analysis.Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.Highly sensitive potentiometric strip test for detecting high charge density impurities in heparin.Linear polyalkylamines as fingerprinting agents in capillary electrophoresis of low-molecular-weight heparins and glycosaminoglycans.Protocol for the purification of protected carbohydrates: toward coupling automated synthesis to alternate-pump recycling high-performance liquid chromatography.Method to detect contaminants in heparin using radical depolymerization and liquid chromatography-mass spectrometry.Electrophoresis for the analysis of heparin purity and quality.Quantitative NMR for bioanalysis and metabolomics.The heparin recall of 2008.Recent advances in capillary electrophoretic migration techniques for pharmaceutical analysis.Adenosine-based molecular beacons as light-up probes for sensing heparin in plasma.Surface modification and endothelialization of biomaterials as potential scaffolds for vascular tissue engineering applications.Ion chromatography for the separation of heparin and structurally related glycoaminoglycans: A review.Neutralizing the anticoagulant activity of ultra-low-molecular-weight heparins using N-acetylglucosamine 6-sulfatase.Affinity capillary electrophoresis for the determination of binding affinities for low molecular weight heparins and antithrombin-III.A robust method to quantify low molecular weight contaminants in heparin: detection of tris(2-n-butoxyethyl) phosphate.A KISS (keep it simple, sensor) array for glycosaminoglycans.Analysis of glycosaminoglycan-derived, precolumn, 2-aminoacridone-labeled disaccharides with LC-fluorescence and LC-MS detection.Efficacy of Chitosan-Based Dressing for Control of Bleeding in Excisional Wounds.Recent Liquid Chromatographic Approaches and Developments for the Separation and Purification of Carbohydrates.High-sensitivity visualisation of contaminants in heparin samples by spectral filtering of 1H NMR spectra
P2860
Q27682019-EDDEBF98-6942-4B8E-BE07-52118AA4E07EQ33807044-C5D74C4C-B922-4264-B4B2-79113FA137E1Q33934159-6E53A534-A65F-42A2-ADCE-283019EEDC4EQ35834651-D5FC647C-93C6-4725-81DA-BBED095A0739Q36452315-291FF7BF-0C06-42EB-9445-FB3B1F0AF1CBQ37441353-5144DD90-DE74-4AFD-820C-426F5C628AEFQ37589975-74A2B4C2-B360-451C-84E3-122033EBDEBBQ38021961-964F12FB-2E93-422D-BB52-2ED2FA0F6E98Q38024261-034625A0-0B0E-48F5-9349-7C021D79892FQ38050126-0B0DA7EC-624B-4E53-A36C-3C66240A49AFQ38176306-7EBE7E58-4C3B-40DA-9E60-40C72CEC0BE3Q38316502-0BFB3DCD-E1BC-455F-8580-AA458A190F85Q38507265-50C66AEA-FAF2-4167-A12E-9A9E65B0565CQ38708130-5D113B44-645F-4632-AD2E-55E690DA4B6AQ41775393-1BF6631E-8401-48A1-AABC-19041486774FQ46070632-222D3997-6F69-4843-8612-B250B43C2622Q47381040-032D9219-ECBB-4AD1-B80C-3122324D78BFQ50922773-37B9596B-9BA7-4717-BC9F-856EF19D1F89Q53625004-79030817-DA55-44CE-88C1-2AECBF4B63CFQ54917660-CBF78B31-1FAB-4EB4-8169-331FA277BDBDQ55524303-ADA1045C-3BEB-4114-964D-2D8E367A62E2Q56833682-E855EB81-FB95-41B8-BB4A-5594610CCC0C
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Analysis and characterization of heparin impurities
@ast
Analysis and characterization of heparin impurities
@en
Analysis and characterization of heparin impurities
@nl
type
label
Analysis and characterization of heparin impurities
@ast
Analysis and characterization of heparin impurities
@en
Analysis and characterization of heparin impurities
@nl
prefLabel
Analysis and characterization of heparin impurities
@ast
Analysis and characterization of heparin impurities
@en
Analysis and characterization of heparin impurities
@nl
P2860
P1476
Analysis and characterization of heparin impurities
@en
P2093
John F K Limtiaco
Szabolcs Beni
P2860
P2888
P304
P356
10.1007/S00216-010-4121-X
P407
P577
2011-01-01T00:00:00Z
P5875
P6179
1003629619